Form 8-K - Current report:
SEC Accession No. 0001213900-26-082879
Filing Date
2026-07-29
Accepted
2026-07-29 17:02:11
Documents
16
Period of Report
2026-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0299510-8k_onconetix.htm   iXBRL 8-K 52782
2 CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES F PREFERRED S ea029951001ex3-1.htm EX-3.1 350444
3 FORM OF SECURITIES PURCHASE AGREEMENT DATED JULY 28, 2026 RELATING TO THE SALE O ea029951001ex10-1.htm EX-10.1 354941
4 FORM OF REGISTRATION RIGHTS AGREEMENT DATED JULY 28, 2026 RELATING TO THE RESALE ea029951001ex10-2.htm EX-10.2 170706
5 FORM OF ELOC PURCHASE AGREEMENT DATED JULY 28, 2026 ea029951001ex10-3.htm EX-10.3 355292
6 FORM OF ELOC REGISTRATION RIGHTS AGREEMENT DATED JULY 28, 2026 ea029951001ex10-4.htm EX-10.4 150549
  Complete submission text file 0001213900-26-082879.txt   1926543

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE onco-20260728.xsd EX-101.SCH 3075
9 XBRL LABEL FILE onco-20260728_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE onco-20260728_pre.xml EX-101.PRE 22360
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0299510-8k_onconetix_htm.xml XML 3323
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 261218744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)